Blog

Nov 7, 2022

Lab-grown blood cells transfused into two patients in a world-first clinical trial

Posted by in categories: biotech/medical, innovation

The trial that could transform care for people with blood disorders such as sickle cell and rare blood types.

In what can be called a breakthrough in medical science, red blood cells grown in a laboratory have been transfused into volunteers in a world-first clinical trial.

The manufactured blood cells — grown from donor stem cells — could revolutionize treatments for people with blood disorders such as sickle cell disease if proven to be safe and effective.

Comments are closed.